A Cheshire-based MedTech has secured £4.5 million of investment and grant funding to help transform treatment for glioblastoma (GBM) and potentially extend thousands of lives each year. QV Bioelectronics, based at Alderley Park, is said to have developed a world-first implantable device designed to improve outcomes for patients with hard-to-treat GBM.  Cancer Research UK says … Continue reading MedTech developing ‘world-first’ GBM treatment raises £4.5m